Here is a high-level review of the manufacturing contracts between the U.S. DOD and Moderna. Moderna’s injection, mRNA-1273, is co-owned with the U.S. government, as the company has been funded by defense research grants for years and also received intellectual property transfers from the U.S. government, in addition to preclinical and clinical research work conducted […]